Anne Vanlent bought TRVI once, on May 9, 2019
Director at Trevi Therapeutics, Inc.
SEC CIK 0001229243 · Filings on SEC.gov ↗
$50KBought
$0Sold
May 13Last buy
Anne Vanlent's record
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
1 filing since May 2019, newest first
Filings come from SEC EDGAR. Not investment advice.